… fixed or free ICS/LABA/LAMA combination therapy with fixed or free LABA/LAMA combination
therapy and single long-acting bronchodilator therapy were included in this meta-analysis. …

… Bronchodilators had no effect on hospitalization (relative risk, 0.85; 95% CI, 0.47 to 1.53;
P=.58), but co-interventions may have been administered prior to this outcome. The results for …

… open and closed dual-combination bronchodilators in patients with moderate-to-very severe
COPD who were eligible to receive maintenance bronchodilator therapy. Four endpoints, …

… This meta-analysis suggests that patients on single long-acting bronchodilator therapy or
LABA/LAMA … and single long-acting bronchodilator therapy were included in this meta-analysis. …

… Conclusions: Bronchodilator delivery by means of an MDI or … Spacer devices were used for
bronchodilator delivery with an … than standard doses of bronchodilators delivered by use of …

… systematic reviews on dual combination inhalers and long‐acting bronchodilators to
answer the questions described above using the strength of a network meta‐analysis (NMA). …

… the current analysis was to evaluate the comparative efficacy of long-acting bronchodilators
in … Approved bronchodilators or those for which data was available at the time of the literature …

… Pairwise random-effects meta-analysis revealed an increase in risk of pneumonia (… triple
therapy compared with treatment with dual and monotherapy long-acting bronchodilator therapy…

… analysis, approved indacaterol only at a dose of 75 μg once daily for long-term bronchodilator
… Our preclinical data and the results of this meta-analysis give support to the use of dosage …

… analysis of randomized controlled trials (RCTs) with dual long-acting bronchodilator therapy
… objective of this meta-analysis is to evaluate the efficacy of dual therapy with LABA + LAMA …